MyFinsight
Home
Blog
About
Neurogene Inc. (NGNE)
Neurogene Inc. (NGNE)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$8,640K
Free Cash flow
-$50,515K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from maturities of held...
Stock-based compensation expense
Proceeds from sale of common sto...
Others
Negative Cash Flow Breakdown
Purchases of held-to-maturity in...
Net loss
Operating lease liabilities
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Total research and development expenses
-
-
54,372
-
Total general and administrative expenses
-
-
21,427
-
Other income
-
-
10,183
-
Net loss
-65,422
-24,735
-65,616
-
Stock-based compensation expense
11,491
3,362
3,365
7,456
Depreciation and impairment of property and equipment
1,660
776
764
1,503
Asset impairment
-
120
0
0
Non-cash operating lease expense
385
194
207
399
Amortization of finance lease right-of-use assets
14
11
12
26
Amortization and accretion of premiums/discounts on held-to-maturity investments
718
500
816
3,220
Change in contingent value rights liability
-659
1
-822
78
Gain on lease modification
-
6
-
-
Prepaid expenses and other current assets
774
-2,318
417
949
Other assets
74
-30
-33
121
Accounts payable
1,298
409
-501
719
Accrued expenses and other liabilities
4,454
1,331
365
-31
Operating lease liabilities
-1,535
-740
-745
-1,433
Net cash used in operating activities
-49,880
-17,429
-19,508
-40,236
Purchases of property and equipment
635
128
127
928
Purchases of held-to-maturity investments
196,161
42,763
77,383
149,367
Offering costs in connection with pre-closing financing
-
0
0
0
Proceeds from maturities of held-to-maturity investments
249,140
72,500
99,500
112,700
Transaction costs related to reverse merger
-
0
0
0
Net cash provided by (used in) investing activities
52,344
29,609
21,990
-37,595
Proceeds from the issuance of common stock upon exercise of options
223
90
89
87
Proceeds from private financing, net of offering costs paid
-
0
-
-
Principal payments on finance leases
11
19
13
29
Proceeds from sale of common stock in at-the-market offering, net of offering costs
5,914
-
-
-
Proceeds from the issuance of common stock under the 2023 employee stock purchase plan
67
20,580
9,800
-
Proceeds from the issuance of common stock under employee stock purchase plan
-
84
-
-
Deferred costs related to offering
17
75
166
-
Net cash provided by financing activities
6,176
20,660
9,710
58
Net increase (decrease) in cash, cash equivalents and restricted cash
8,640
32,840
12,192
-77,773
Cash, cash equivalents and restricted cash at beginning of period
104,184
71,344
136,925
-
Cash, cash equivalents and restricted cash at end of period
112,824
104,184
71,344
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from maturities
of...
$249,140K
(121.06%↑ Y/Y)
Proceeds from sale of
common stock in...
$5,914K
Proceeds from the
issuance of common stock...
$223K
(156.32%↑ Y/Y)
Proceeds from the
issuance of common stock...
$67K
Net cash provided by
(used in) investing...
$52,344K
(239.23%↑ Y/Y)
Net cash provided by
financing activities
$6,176K
(10548.28%↑ Y/Y)
Canceled cashflow
$196,796K
Canceled cashflow
$28K
Net increase
(decrease) in cash, cash...
$8,640K
(111.11%↑ Y/Y)
Canceled cashflow
$49,880K
Purchases of
held-to-maturity investments
$196,161K
(31.33%↑ Y/Y)
Purchases of property and
equipment
$635K
(-31.57%↓ Y/Y)
Stock-based compensation
expense
$11,491K
(54.12%↑ Y/Y)
Accrued expenses and
other liabilities
$4,454K
(14467.74%↑ Y/Y)
Depreciation and impairment
of property and...
$1,660K
(10.45%↑ Y/Y)
Accounts payable
$1,298K
(80.53%↑ Y/Y)
Non-cash operating lease
expense
$385K
(-3.51%↓ Y/Y)
Amortization of finance lease
right-of-use assets
$14K
(-46.15%↓ Y/Y)
Deferred costs related to
offering
$17K
Principal payments on
finance leases
$11K
(-62.07%↓ Y/Y)
Net cash used in
operating activities
-$49,880K
(-23.97%↓ Y/Y)
Canceled cashflow
$19,302K
Net loss
-$65,422K
Operating lease
liabilities
-$1,535K
(-7.12%↓ Y/Y)
Prepaid expenses and
other current assets
$774K
(-18.44%↓ Y/Y)
Amortization and accretion of
premiums/discounts on...
$718K
(-77.70%↓ Y/Y)
Change in contingent
value rights...
-$659K
(-944.87%↓ Y/Y)
Other assets
$74K
(-38.84%↓ Y/Y)
Buy us a coffee